Cover Image
Market Research Report
Product code 
1070510

Transcriptomics Market by Type, Technology, Application : Global Opportunity Analysis and Industry Forecast, 2021-2030

Published: | Allied Market Research | 215 Pages | Delivery time: 2-3 business days

Price

Back to Top
Transcriptomics Market by Type, Technology, Application : Global Opportunity Analysis and Industry Forecast, 2021-2030
Published: February 27, 2022
Allied Market Research
Content info: 215 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The transcriptomics market was valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.Transcriptomics is the collection and study of RNA present in different types of cells and tissues in an organism. It is a promising tool for discovery of basic gene expression patterns, determination of drug-induced toxicity in adverse drug reactions, and other uses in the medical field. It is an analysis of transcriptome. RNA performs many functions within the cell and studying the transcriptome provides insights into how genes are working and whether proteins are being produced.

Increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and rise in application of transcriptomics such as drug discovery are expected to drive the growth of the market. Moreover, other factors that fuel the market growth include increase in adoption of transcriptomics products and rise in demand for personalized medicine. In addition, many companies have increased their market presence, thereby expanding their business across new markets. For instance, in February 2020, Dovetail Genomics announced the launch of its Dovetail HichlP and Micro-C kits. These aforementioned factors have led to increase in the growth of the transcriptomics market.

Furthermore, the high demand for diagnostic of inflammatory diseases such as COVID-19, and rise in production of transcriptomics instruments to boost the growth of the market. In addition, in February 2020, Caris Life Sciences launched its new MI transcriptome, which enables whole transcriptome sequencing. MI transcriptome uses the high capability of sequencing to gain insight into the RNA profiles of tumor patients. Thus, increased availability of transcriptomics instruments propels the growth of the transcriptomics market.

Conversely, high capital investment in the implementation of transcriptomics is anticipated to hinder the market growth. People, nowadays are more aware of health, which, in turn, compels them to maintain their health condition and increase demand for diagnosis of various diseases. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the transcriptomics market.

The global transcriptomics market is segmented on the basis of type, technology, application, and region. By type, the market is categorized into consumables, instruments, software, and services.

On the basis of technology, the market is divided into microarrays, q PCR, and sequencing technology.

Depending on application, it is fragmented into drug discovery, diagnostics, disease profiling, and others. On the basis of end user, it is divided into government institutes & academic centers, pharmaceutical & biotechnology companies and contract research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global transcriptomics market are Agilent Technologies Inc, Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, QiagenInc, and ThermoFisher Scientific.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global transcriptomics market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region- & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Product& Services Type

  • Consumables
  • Instruments
  • Software
  • Services

By Technology

  • Microarrays
  • q PCR
  • Sequencing Technology

By Application

  • Drug Discovery
  • Diagnostics and Disease Profiling
  • Others

By End User

  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories
  • F-Hoffmann La-Roche
  • Fluidigm Corporation
  • General Electric Company
  • Illuminia Inc. *
  • Merck & Co. Inc *
  • Promega Corporation
  • QiagenInc *
  • Thermofisher Scientific
Product Code: LI_182595 / A02263

TABLE OF CONTENTS

CHAPTER 1INTRODUCTION

  • 1.1.report description
  • 1.2.key benefits for stakeholders
  • 1.3.key market segments
  • 1.4.research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2EXECUTIVE SUMMARY

  • 2.1.key findings of the study
  • 2.2.cxo perspective

CHAPTER 3MARKET OVERVIEW

  • 3.1.market definition and scope
  • 3.2.Top investment pockets
  • 3.3.market share analysis
  • 3.4.market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Technological advancements in transcriptomics
      • 3.4.1.2.Increase in applications of transcriptomics
      • 3.4.1.3.Increase in research grants
      • 3.4.1.4.Increase in genome mapping programs
    • 3.4.2.Restraints
      • 3.4.2.1.Standardization concerns over RNA sequencing
      • 3.4.2.2.Lack of skilled professionals
    • 3.4.3.Opportunity
      • 3.4.3.1.Lucrative opportunities in emerging markets
    • 3.4.4.Impact analysis
  • 3.5.clinical trials

CHAPTER 4TRANSCRIPTOMICS MARKET, BY TECHNOLOGY

  • 4.1.overview
    • 4.1.1.Market size and forecast
  • 4.2.microarray
    • 4.2.1.Key market trends, growth factors and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Real-time quantitative Polymerase chain reaction(qPCR)
    • 4.3.1.Key market trends, growth factors and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Sequencing technologies
    • 4.4.1.Key market trends, growth factors and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country
    • 4.4.4.Market size and forecast, by type
      • 4.4.4.1.Sanger sequencing
      • 4.4.4.1.1.Market size and forecast
      • 4.4.4.2.RNA sequencing
      • 4.4.4.2.1.Market size and forecast

CHAPTER 5TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES

  • 5.1.overview
    • 5.1.1.Market size and forecast
  • 5.2.Consumables
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Instruments
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Software
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Services
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country

CHAPTER 6TRANSCRIPTOMICS MARKET, BY APPLICATION

  • 6.1.overview
    • 6.1.1.Market size and forecast
  • 6.2.diagnostics & disease profiling
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.drug discovery
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.others
    • 6.4.1.Market size and forecast, by region
    • 6.4.2.Market analysis, by country

CHAPTER 7TRANSCRIPTOMICS MARKET, BY END USER

  • 7.1.overview
    • 7.1.1.Market size and forecast
  • 7.2.Government Institutes & Academic Centers
    • 7.2.1.Market size and forecast, by region
    • 7.2.2.Market analysis, by country
  • 7.3.pharmaceutical & biotechnologY companies
    • 7.3.1.Market size and forecast, by region
    • 7.3.2.Market analysis, by country
  • 7.4.Contract research organization
    • 7.4.1.Market size and forecast, by region
    • 7.4.2.Market analysis, by country

CHAPTER 8TRANSCRIPTOMICS MARKET, BY REGION

  • 8.1.overview
    • 8.1.1.Market size and forecast
  • 8.2.north america
    • 8.2.1.Key market trends, growth factors and opportunities
    • 8.2.2.North America market size and forecast, by country
      • 8.2.2.1.U.S. transcriptomics market
      • 8.2.2.1.1.U.S. market size and forecast, by technology
      • 8.2.2.1.2.U.S. market size and forecast, by products & services
      • 8.2.2.1.3.U.S. market size and forecast, by application
      • 8.2.2.1.4.U.S. market size and forecast, by end user
      • 8.2.2.2.Canada transcriptomics market
      • 8.2.2.2.1.Canada market size and forecast, by technology
      • 8.2.2.2.2.Canada market size and forecast, by products & services
      • 8.2.2.2.3.Canada market size and forecast, by application
      • 8.2.2.2.4.Canada market size and forecast, by end user
      • 8.2.2.3.Mexico transcriptomics market
      • 8.2.2.3.1.Mexico market size and forecast, by technology
      • 8.2.2.3.2.Mexico market size and forecast, by products & services
      • 8.2.2.3.3.Mexico market size and forecast, by application
      • 8.2.2.3.4.Mexico market size and forecast, by end user
    • 8.2.3.North America market size and forecast, by technology
    • 8.2.4.North America market size and forecast, by products & services
    • 8.2.5.North America market size and forecast, by application
    • 8.2.6.North America market size and forecast, by end user
  • 8.3.europe
    • 8.3.1.Key market trends, growth factors and opportunities
    • 8.3.2.Europe market size and forecast, by country
      • 8.3.2.1.Germany transcriptomics market
      • 8.3.2.1.1.Germany market size and forecast, by technology
      • 8.3.2.1.2.Germany market size and forecast, by products & services
      • 8.3.2.1.3.Germany market size and forecast, by application
      • 8.3.2.1.4.Germany market size and forecast, by end user
      • 8.3.2.2.France transcriptomics market
      • 8.3.2.2.1.France market size and forecast, by technology
      • 8.3.2.2.2.France market size and forecast, by products & services
      • 8.3.2.2.3.France market size and forecast, by application
      • 8.3.2.2.4.France market size and forecast, by end user
      • 8.3.2.3.UK transcriptomics market
      • 8.3.2.3.1.UK market size and forecast, by technology
      • 8.3.2.3.2.UK market size and forecast, by products & services
      • 8.3.2.3.3.UK market size and forecast, by application
      • 8.3.2.3.4.UK market size and forecast, by end user
      • 8.3.2.4.Italy transcriptomics market
      • 8.3.2.4.1.Italy market size and forecast, by technology
      • 8.3.2.4.2.Italy market size and forecast, by products & services
      • 8.3.2.4.3.Italy market size and forecast, by application
      • 8.3.2.4.4.Italy market size and forecast, by end user
      • 8.3.2.5.Spain transcriptomics market
      • 8.3.2.5.1.Spain market size and forecast, by technology
      • 8.3.2.5.2.Spain market size and forecast, by products & services
      • 8.3.2.5.3.Spain market size and forecast, by application
      • 8.3.2.5.4.Spain market size and forecast, by end user
      • 8.3.2.6.Rest of Europe transcriptomics market
      • 8.3.2.6.1.Rest of Europe market size and forecast, by technology
      • 8.3.2.6.2.Rest of Europe market size and forecast, by products & services
      • 8.3.2.6.3.Rest of Europe market size and forecast, by application
      • 8.3.2.6.4.Rest of Europe market size and forecast, by end user
    • 8.3.3.Europe market size and forecast, by technology
    • 8.3.4.Europe market size and forecast, by products & services
    • 8.3.5.Europe market size and forecast, by application
    • 8.3.6.Europe market size and forecast, by end user
  • 8.4.asia-pacific
    • 8.4.1.Key market trends, growth factors and opportunities
    • 8.4.2.Asia-Pacific market size and forecast, by country
      • 8.4.2.1.Japan transcriptomics market
      • 8.4.2.1.1.Japan market size and forecast, by technology
      • 8.4.2.1.2.Japan market size and forecast, by products & services
      • 8.4.2.1.3.Japan market size and forecast, by application
      • 8.4.2.1.4.Japan market size and forecast, by end user
      • 8.4.2.2.China transcriptomics market
      • 8.4.2.2.1.China market size and forecast, by technology
      • 8.4.2.2.2.China market size and forecast, by products & services
      • 8.4.2.2.3.China market size and forecast, by application
      • 8.4.2.2.4.China market size and forecast, by end user
      • 8.4.2.3.India transcriptomics market
      • 8.4.2.3.1.India market size and forecast, by technology
      • 8.4.2.3.2.India market size and forecast, by products & services
      • 8.4.2.3.3.India market size and forecast, by application
      • 8.4.2.3.4.India market size and forecast, by end user
      • 8.4.2.4.Australia transcriptomics market
      • 8.4.2.4.1.Australia market size and forecast, by technology
      • 8.4.2.4.2.Australia market size and forecast, by products & services
      • 8.4.2.4.3.Australia market size and forecast, by application
      • 8.4.2.4.4.Australia market size and forecast, by end user
      • 8.4.2.5.Rest of Asia-Pacific transcriptomics market
      • 8.4.2.5.1.Rest of Asia-Pacific market size and forecast, by technology
      • 8.4.2.5.2.Rest of Asia-Pacific market size and forecast, by products & services
      • 8.4.2.5.3.Rest of Asia-Pacific market size and forecast, by application
      • 8.4.2.5.4.Rest of Asia-Pacific market size and forecast, by end user
    • 8.4.3.Asia-Pacific market size and forecast, by technology
    • 8.4.4.Asia-Pacific market size and forecast, by products & services
    • 8.4.5.Asia-Pacific market size and forecast, by application
    • 8.4.6.Asia-Pacific market size and forecast, by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends, growth factors and opportunities
    • 8.5.2.LAMEA market size and forecast, by country
      • 8.5.2.1.Brazil transcriptomics market
      • 8.5.2.1.1.Brazil market size and forecast, by technology
      • 8.5.2.1.2.Brazil market size and forecast, by products & services
      • 8.5.2.1.3.Brazil market size and forecast, by application
      • 8.5.2.1.4.Brazil market size and forecast, by end user
      • 8.5.2.2.South Africa transcriptomics market
      • 8.5.2.2.1.South Africa market size and forecast, by technology
      • 8.5.2.2.2.South Africa market size and forecast, by products & services
      • 8.5.2.2.3.South Africa market size and forecast, by application
      • 8.5.2.2.4.South Africa market size and forecast, by end user
      • 8.5.2.3.Saudi Arabia transcriptomics market
      • 8.5.2.3.1.Saudi Arabia market size and forecast, by technology
      • 8.5.2.3.2.Saudi Arabia market size and forecast, by products & services
      • 8.5.2.3.3.Saudi Arabia market size and forecast, by application
      • 8.5.2.3.4.Saudi Arabia market size and forecast, by end user
      • 8.5.2.4.Rest of LAMEA transcriptomics market
      • 8.5.2.4.1.Rest of LAMEA market size and forecast, by technology
      • 8.5.2.4.2.Rest of LAMEA market size and forecast, by products & services
      • 8.5.2.4.3.Rest of LAMEA market size and forecast, by application
      • 8.5.2.4.4.Rest of LAMEA market size and forecast, by end user
    • 8.5.3.LAMEA market size and forecast, by technology
    • 8.5.4.LAMEA market size and forecast, by products & services
    • 8.5.5.LAMEA market size and forecast, by application
    • 8.5.6.LAMEA market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.Agilent Technologies Inc.
    • 1.1.1.Company overview
    • 1.1.2.Company snapshot
    • 1.1.3.Operating business segments
    • 1.1.4.Product portfolio
    • 1.1.5.Business performance
    • 1.1.6.Key strategic moves and developments
  • 9.2.Bio-rad Laboratories Inc.
    • 1.2.1.Company overview
    • 1.2.2.Company snapshot
    • 1.2.3.Operating business segments
    • 1.2.4.Product portfolio
    • 1.2.5.Business performance
    • 1.2.6.Key strategic moves and developments
  • 9.3.F-Hoffmann-La-Roche
    • 1.3.1.Company overview
    • 1.3.2.Company snapshot
    • 1.3.3.Operating business segments
    • 1.3.4.Product portfolio
    • 1.3.5.Business performance
    • 1.3.6.Key strategic moves and developments
  • 9.4.Fluidigm Corporation
    • 1.4.1.Company overview
    • 1.4.2.Company snapshot
    • 1.4.3.Operating business segments
    • 1.4.4.Product portfolio
    • 1.4.5.Business performance
    • 1.4.6.Key strategic moves and developments
  • 9.5.General Electric Company (GE Healthcare)
    • 1.5.1.Company overview
    • 1.5.2.Company snapshot
    • 1.5.3.Operating business segments
    • 1.5.4.Product portfolio
    • 1.5.5.Business performance
  • 9.6.Illumina Inc.
    • 1.6.1.Company overview
    • 1.6.2.Operating business segments
    • 1.6.3.Product portfolio
    • 1.6.4.Business performance
  • 9.7.Merck & Co. Inc.
    • 1.7.1.Company overview
    • 1.7.2.Company snapshot
    • 1.7.3.Operating business segments
    • 1.7.4.Product portfolio
    • 1.7.5.Business performance
  • 9.8.Promega Corporation
    • 1.8.1.Company overview
    • 1.8.2.Company snapshot
    • 1.8.3.Operating business segments
    • 1.8.4.Product portfolio
  • 9.9.QIAGEN N.V.
    • 1.9.1.Company overview
    • 1.9.2.Company snapshot
    • 1.9.3.Operating business segments
    • 1.9.4.Product portfolio
    • 1.9.5.Business performance
  • 9.10.Thermo Fisher Scientific Inc.
    • 1.10.1.Company overview
    • 1.10.2.Company snapshot
    • 1.10.3.Operating business segments
    • 1.10.4.Product portfolio
    • 1.10.5.Business performance

LIST OF TABLES

  • TABLE 1.GLOBAL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 2.MICROARRAY MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 3.QPCR MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 4.SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 5.GLOBAL SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 6.COMPARISON BETWEEN RNA-SEQUENCING AND EXPRESSION MICROARRAYS
  • TABLE 7.GLOBAL TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 8.PRODUCTS FOR ENRICHMENT
  • TABLE 9.CONSUMBALES MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 10.NGS PLATFORMS AVAILABLE FOR RNA-SEQUENCING
  • TABLE 11.INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 12.SOFTWARE MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 13.SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 14.GLOBAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 15.DIAGNOSTICS & DISEASE PROFILING MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 16.DRUG DISCOVERY MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 17.OTHER APPLICATIONS MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 18.GLOBAL TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 19.GOVERNMENT INSTITUTES & ACADEMIC CENTERS MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 20.PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 21.CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 22.TRANSCRIPTOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 23.NORTH AMERICA TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
  • TABLE 24.U.S. TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 25.U.S. TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 26.U.S. TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 27.U.S. TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 28.CANADA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 29.CANADA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 30.CANADA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 31.CANADA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 32.MEXICO TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 33.MEXICO TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 34.MEXICO TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 35.MEXICO TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 36.NORTH AMERICA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 37.NORTH AMERICA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 38.NORTH AMERICA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 39.NORTH AMERICA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 40.EUROPE TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
  • TABLE 41.GERMANY TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 42.GERMANY TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 43.GERMANY TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 44.GERMANY TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 45.FRANCE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 46.FRANCE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 47.FRANCE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 48.FRANCE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 49.UK TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 50.UK TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 51.UK TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 52.UK TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 53.ITALY TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 54.ITALY TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 55.ITALY TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 56.ITALY TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 57.SPAIN TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 58.SPAIN TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 59.SPAIN TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 60.SPAIN TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 61.REST OF EUROPE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 62.REST OF EUROPE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 63.REST OF EUROPE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 64.REST OF EUROPE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 65.EUROPE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 66.EUROPE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 67.EUROPE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 68.EUROPE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 69.ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
  • TABLE 70.JAPAN TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 71.JAPAN TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 72.JAPAN TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 73.JAPAN TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 74.CHINA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 75.CHINA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 76.CHINA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 77.CHINA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 78.INDIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 79.INDIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 80.INDIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 81.INDIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 82.AUSTRALIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 83.AUSTRALIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 84.AUSTRALIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 85.AUSTRALIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 86.REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 87.REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 88.REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 89.REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 90.ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 91.ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 92.ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 93.ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 94.LAMEA TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
  • TABLE 95.BRAZIL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 96.BRAZIL TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 97.BRAZIL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 98.BRAZIL TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 99.SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 100.SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 101.SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 102.SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 103.SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 104.SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 105.SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 106.SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 107.REST OF LAMEA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 108.REST OF LAMEA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 109.REST OF LAMEA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 110.REST OF LAMEA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 111.LAMEA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
  • TABLE 112.LAMEA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
  • TABLE 113.LAMEA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 114.LAMEA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 115.AGILENT: COMPANY SNAPSHOT
  • TABLE 116.AGILENT: OPERATING SEGMENTS
  • TABLE 117.AGILENT: PRODUCT PORTFOLIO
  • TABLE 118.BIO-RAD: COMPANY SNAPSHOT
  • TABLE 119.BIO-RAD: OPERATING SEGMENTS
  • TABLE 120.BIO-RAD: PRODUCT PORTFOLIO
  • TABLE 121.GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 122.GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 123.GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 124.ROCHE: COMPANY SNAPSHOT
  • TABLE 125.ROCHE: PRODUCT CATEGORIES
  • TABLE 126.ROCHE: PRODUCT PORTFOLIO
  • TABLE 127.FLUIDIGM: COMPANY SNAPSHOT
  • TABLE 128.FLUIDIGM: OPERATING SEGMENTS
  • TABLE 129.FLUIDIGM: PRODUCT PORTFOLIO
  • TABLE 130.ILLUMINA: COMPANY SNAPSHOT
  • TABLE 131.ILLUMINA: OPERATING SEGMENTS
  • TABLE 132.ILLUMINA: PRODUCT PORTFOLIO
  • TABLE 133.MERCK: COMPANY SNAPSHOT
  • TABLE 134.MERCK: OPERATING SEGMENTS
  • TABLE 135.MERCK: PRODUCT PORTFOLIO
  • TABLE 136.PROMEGA: COMPANY SNAPSHOT
  • TABLE 137.PROMEGA: PRODUCT CATEGORIES
  • TABLE 138.PROMEGA: PRODUCT PORTFOLIO
  • TABLE 139.QIAGEN: COMPANY SNAPSHOT
  • TABLE 140.QIAGEN: OPERATING SEGMENTS
  • TABLE 141.QIAGEN: PRODUCT PORTFOLIO
  • TABLE 142.THERMO FISHER: COMPANY SNAPSHOT
  • TABLE 143.THERMO FISHER: OPERATING SEGMENTS
  • TABLE 144.THERMO FISHER: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 1.TRANSCRIPTOMICS MARKET SEGMENTATION
  • FIGURE 2.TOP INVESTMENT POCKETS, 2016
  • FIGURE 3.MARKET SHARE ANALYSIS, 2016
  • FIGURE 4.IMPACT ANALYSIS, 2016
  • FIGURE 5.GEOGRAPHICAL DISTRIBUTION OF TRANSCRIPTOMICS CLINICAL TRIALS
  • FIGURE 6.TRANSCRIPTOMICS CLINICAL TRIALS, BY PHASE
  • FIGURE 7.COMPARATIVE ANALYSIS OF MICROARRAY MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 8.COMPARATIVE ANALYSIS OF QPCR MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 9.COMPARATIVE ANALYSIS OF SEQUENCING TECHNOLOGIES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 10.SANGER SEQUENCING MARKET, 2016-2023 ($MILLION)
  • FIGURE 11.RNA SEQUENCING MARKET, 2016-2023 ($MILLION)
  • FIGURE 12.COMPARATIVE ANALYSIS OF CONSUMABLES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 13.COMPARATIVE ANALYSIS OF INSTRUMENTS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF SOFTWARE MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF SERVICES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF DIAGNOSTICS & DISEASE PROFILING MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF DRUG DISCOVERY MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF GOVERNMENT INSTITUTES & ACADEMIC CENTERS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
  • FIGURE 22.AGILENT: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 23.AGILENT: REVENUE BY SEGMENT, 2016 (%)
  • FIGURE 24.AGILENT: REVENUE BY REGION, 2016 (%)
  • FIGURE 25.BIO-RAD: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 26.BIO-RAD: REVENUE BY SEGMENT, 2016 (%)
  • FIGURE 27.BIO-RAD: REVENUE, BY REGION, 2016 (%)
  • FIGURE 28.GE HEALTHCARE: NET SALES, 2014-2016($MILLION)
  • FIGURE 29.GE HEALTHCARE: REVENUE SHARE BY PRODUCT, 2016 (%)
  • FIGURE 30.GE HEALTHCARE: REVENUE SHARE BY REGION, 2016 (%)
  • FIGURE 31.ROCHE: NET-SALES, 2014-2016 ($MILLION)
  • FIGURE 32.ROCHE: REVENUE SHARE BY SEGMENT, 2016 (%)
  • FIGURE 33.ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
  • FIGURE 34.FLUIDIGM: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 35.FLUIDIGM: REVENUE BY SEGMENT, 2016 (%)
  • FIGURE 36.FLUIDIGM: REVENUE BY REGION, 2016 (%)
  • FIGURE 37.ILLUMINA: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 38.ILLUMINA: REVENUE BY REGION, 2016 (%)
  • FIGURE 39.MERCK: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 40.MERCK: REVENUE BY SEGMENT, 2016 (%)
  • FIGURE 41.MERCK: REVENUE BY REGION, 2016 (%)
  • FIGURE 42.QIAGEN: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 43.QIAGEN: REVENUE BY PRODUCTS, 2016 (%)
  • FIGURE 44.QIAGEN: REVENUE BY REGION, 2016 (%)
  • FIGURE 45.THERMO FISHER: NET SALES, 2014-2016 ($MILLION)
  • FIGURE 46.THERMO FISHER: REVENUE BY SEGMENT, 2016 (%)
  • FIGURE 47.THERMO FISHER: REVENUE BY REGION, 2016 (%)